Drug intelligence / Profile preview

FluLaval TF

Development stage
Approved
Lead developer
GSK
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

FluLaval TF is a preservative-free, thimerosal-free formulation of FluLaval, an inactivated, split-virion influenza vaccine prepared from influenza A subtype and influenza B viruses propagated in embryonated hens’ eggs and inactivated with ultraviolet light and formaldehyde before purification and disruption with detergent. It is designed for intramuscular administration to induce strain-specific neutralizing antibodies against the hemagglutinin antigens of the included influenza viruses, thereby providing active immunization for the prevention of seasonal influenza. Developed by GSK, this formulation maintains the antigenic composition and immunogenic profile of standard FluLaval while removing thimerosal from the presentation to meet preservative‑free requirements.

Brand names
FluLaval TF
Other names
Influenza Vaccine
02

Targets

γδ TCR (T-cell receptor)BCR (Immunoglobulin G B Cell Receptor)

Beyond the preview

Go deeper on FluLaval TF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FluLaval TF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call